Everyday Health on MSN
Obstructive vs. Nonobstructive Hypertrophic Cardiomyopathy (HCM): What Your Diagnosis Means for Treatment and Lifestyle
Learn the key differences between obstructive and nonobstructive HCM, including how your specific diagnosis can impact symptoms, treatment options, and more.
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Application (MAA) for mavacamten, ...
"This is a historic moment for our company and for the patients we serve, as we fulfill our promise to translate our science into medicines that may make a meaningful difference in patients’ lives,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results